Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 129 for “"Procoagulant"”.
-
Targeting the Procoagulant Platelet
The procoagulant platelet is characterised by its ability to support functional prothrombinase and links primary to secondary haemostasis. Excess procoagulant activity is linked to pathological thrombosis, however the identity of the procoagulant platelet has been elusive to date. Many of the …
-
Procoagulant platelets in health and disease
The procoagulant platelet is a highly activated platelet capable of supporting the assembly of prothrombinase complex resulting in thrombin burst and localisation of fibrin formation to the platelet aggregate clot stabilisation. Excessive procoagulant platelet activity may contribute to …
-
PROCOAGULANT EFFECTS OF PLATINUM-BASED LUNG CANCER CHEMOTHERAPY AGENTS
… (in platinum-based combinations) induce procoagulant effects utilizing in vitro and in vivo approaches. First, we investigated the mechanisms by which lung cancer chemotherapy modulates cell-surface tissue factor (TF) activity on endothelial cells (HUVEC), monocytes, and non-small cell …
-
THE PROCOAGULANT ROLE OF NUCLEIC ACIDS IN THE CONTACT SYSTEM
Nucleic acids have been identified as procoagulant species in plasma and in vivo animal studies. It is believed that the nucleic acids act as physiological activators of the contact system. However, in order to obtain a better understanding of the role of nucleic acids in the activation of the …
-
Procoagulant effects of lung cancer chemotherapy on HUVEC, A549 cells, and monocytes.
… thrombosis remain unclear. We investigated the procoagulant effects of lung cancer chemotherapy agents (carboplatin, paclitaxel, cisplatin, and gemcitabine) on endothelial cells, A549 cells, and monocytes. We also investigated the <em>in </em>vivo procoagulant effects of the aforementioned …
-
Procoagulant and Anti-Fibrinolytic Properties of Cell-free DNA and Histones in Sepsis
Sepsis is a devastating clinical condition characterized by a systemic inflammatory response to infection, with concomitant dysregulated pathological thrombus formation. Although sepsis is triggered by the release of microorganisms and/or microbial toxins into the circulation, the presence of …
-
A study of the characterisation, procoagulant activity and Annexin V binding properties of platelet-derived microparticles.
… platelets from microparticle formation. The procoagulant activity of platelet-derived microparticles was also investigated using a novel coagulation assay (XACT) specific for the procoagulant phospholipid. An evaluation of this assay demonstrated a significant correlation between Annexin V …
-
The procoagulant from Pseudonaja species : isolation and biochemical characterisation and comments on venom variability / Vaughan Keith Williams.
… brown snakes (Pseudonaja spp.) contains a strong procoagulant component that produces bleeding due to consumption of clotting factors in bite victims. Investigation of the role of phospholipid and calcium found neither was essential for activity, but calcium could shorten the clotting time.
-
COMPARISON OF THE PROCOAGULANT AND IMMUNOMODULATORY PROPERTIES OF NUCLEAR, MITOCHONDRIAL, AND BACTERIAL DNA WITH RELEVANCE TO SEPSIS
… infection triggers a systemic inflammatory and procoagulant response. Cell-free DNA (CFDNA) is elevated in sepsis, and correlates with mortality. This DNA may come from nuclear, mitochondrial, or bacterial sources. CpG motifs on bacterial and mitochondrial DNA can stimulate inflammatory …
-
The Development of a Novel in vitro Flow System to Evaluate Platelet Activation and Procoagulant Potential Induced by Bileaflet Mechanical Heart Valve Leakage Jets
… can be used to quantitatively characterize procoagulant potential using a novel in vitro blood flow system. Furthermore, these results can be correlated with digital particle image velocimetry (DPIV) measurements detailing flow fields for the same models. The significant findings were that: …
-
The regulation of blood coagulation by high-density lipoprotein particles
… activation. Anionic phospholipids lost their procoagulant function when incorporated into reconstituted HDL particles. The anionic phospholipids of these particles were unable to support binding to activated factor V (FVa). Serum was also shown to neutralize the procoagulant effect of anionic …
-
Analyses on molecular mechanisms of activation of intravascular Tissue Factor
… are analyzed that could release the TF procoagulant activity of blood components. Tissue factor pathway inhibitor-1 (TFPI) represents the main physiologic inhibitor of the coagulation start. It inhibits the ternary initiator complex of the extrinsic coagulation pathway by first binding …
-
Histidine-rich Glycoprotein: A Novel Regulator of Coagulation and Platelets
… binds polyP with high affinity and inhibits the procoagulant, prothrombotic and cardiotoxic effects of polyP via at least two mechanisms. First, HRG binds polyP and neutralizes its procoagulant activities and cytotoxic effects. Second, HRG binds FXIIa and attenuates its capacity to promote …
-
Analysis of the factor XII-driven contact system activation in vivo
… polyP with phosphatases interfered with procoagulant activity of activated platelets and blocked platelet-induced thrombosis in mice. Infusion of polyP restored defective plasma clotting of Hermansky- Pudlak Syndrome patients, which lack platelet polyP. The data identify polyP as a new …
-
INVESTIGATION OF THE PATHOLOGICAL EFFECTS OF EXTRACELLULAR DNA AND HISTONES IN SEPSIS
… was reported to activate coagulation, but this procoagulant activity has been questioned due to isolation methods that yield DNA that is contaminated with other procoagulant molecules. On the other hand, histones have been shown to not only activate coagulation but are cytotoxic to endothelial …
-
Thrombin generation, Tissue Factor Microvesicles and the Endothelium in Multiple Myeloma and Pancreatic Cancer during treatment.
… tumour stroma especially the endothelium, or any procoagulant changes such as thrombin production due to this interaction; and thus, aimed to study TFMVs involvement through the disruption of endothelial haemostasis. The results presented in this thesis demonstrate that solid and haematological …
-
Blood coagulation reactions on nanoscale membrane surfaces
… reactions not only provide a platform for these procoagulant proteins, but can also affect their function. Increased exposure of acidic phospholipids on the outer leaflet of the plasma membrane can dramatically modulate the catalytic efficiencies of such membrane-bound enzymes. Under physiologic …
-
Circulating cell-derived microparticles – potential markers of cardiovascular risk
… altitude, was shown to cause a decrease in procoagulant, platelet-derived and red blood cell-derived microparticles. Obstructive sleep apnoea is a common syndrome, associated with an increased risk of cardiovascular disease. Microparticle levels were determined in two randomised controlled …
-
A study of coagulation potential in pre-eclampsia
… of measuring maternal plasma microparticle procoagulant activity between pre-eclamptic women and healthy pregnant control women. No significant difference was found in microparticle procoagulant activity between these two groups. However, quantitation of fetal Corticotrophin-Releasing …
-
In vitro μελέτη της αιμοστατικής λειτουργίας των επεξεργασμένων με ριβοφλαβίνη αιμοπεταλίων αφαίρεσης
… hemostatic properties, functionality and procoagulant activity. We observed that PRT adversely affected the metabolic and hemostatic profile of platelets in a time-dependent manner. PRT-treated platelets also showed increased activation and procoagulant activity particularly at the end of …
Page 1 of 7